Innovation In the Chest Pain Pathway – How NHS England Is Leading the Way With Cardiac CT and Artificial Intelligence
Published: 24 March 2022
15m 3sPart 1 Part 1: A Case Based Review With Carlos Collet and Jonathon Leipsic Carlos Collet, Jonathon A Leipsic
According to NICE, HeartFlow FFRct should be considered as an option for patients with stable, recent-onset chest pain who are offered CCTA. Using HeartFlow FFRct may avoid the need for invasive coronary angiography and revascularisation.
Based on the current evidence and assuming there is access to appropriate CCTA facilities, using HeartFlow FFRct may lead to cost savings of £391 per patient .
During this video series, you will learn more about the GIRFT report and its recommendations to understand the role of CT and FFRct as a way to meet demand with capacity and deliver cost savings to the NHS in accordance with the NICE guidance.
In the third part, you will hear about the MedTech Funding Mandate and the experience of CCGs in adopting CT and FFRct to streamline the Chest Pain Pathway and reduce costs.
Find out more about HeartFlow at www.heartflow.com
- Explore the role of non invasive FFRct analysis
- Review clinical evidence supporting clinical utility health economics and safety of HeartFlow analysis
- Insights from high-volume centres in implementing a CT / FFRct pathway
- Learn More about the GIRFT report and its recommendations
- Understand the role of CT and FFRct as a way meet demand with capacity and deliver cost savings to the NHS in accordance with the NICE guidance
- Interventional and general cardiologists
- Cardiac imaging specialists and radiologists
- Cardiac Imagers
- Cardiac CT specialists
- NHS providers-clinical teams and corporate teams
- Integrated Care Boards /Systems
- AHSN technology teams
More from this programme
AI Powered CT Based Non Invasive CAD Testing – The Future Is Now
Insights from the GIRFT Report: Innovation In the Chest Pain Pathway – How NHS England Is Leading the Way With Cardiac CT and Artificial Intelligence
MedTech Funding Mandate and Commissioning Model: Innovation In the Chest Pain Pathway – How NHS England Is Leading the Way With Cardiac CT and Artificial Intelligence
Consultant Interventional Cardiologist
Professor Derek Connolly is a Consultant Interventional Cardiologist and the Director of Research and Development at Birmingham City Hospital. He is an Honorary Senior Clinical Lecturer at the Institute of Cardiovascular Sciences, University of Birmingham, UK.
He trained in Cambridge, London, Edinburgh and San Diego where he was a Carnegie Scholar. He has a first-class degree in Pharmacology from the University of Edinburgh where he was the Brunton medallist and Keasbey Bursary holder. His PhD in molecular cardiology is from the University of Cambridge. He is the Chief or Primary Investigator of multiple large trials in Cardiovascular medicine. He developed one of the UK's first primary angioplasty programmes and one of the UK's largest cardiac CT programmes.
Professor Simon Ray was appointed consultant cardiologist at the University Hospital of South Manchester NHS Trust in 1995, prior to its merger which formed Manchester University NHS Foundation Trust in 2017. He was appointed Honorary Professor of Cardiology at the University of Manchester in 2011. He has served as the president of the British Society of Echocardiography, vice president for clinical standards of the British Cardiovascular Society, and president of the British Heart Valve Society. He is a past president of the British Cardiovascular Society and a member of the board of trustees of the British Heart Foundation.